The Journal of Parenteral and Enteral Nutrition recently
published clinical considerations and best-practice recommendations for
introducing Gattex® (teduglutide [rDNA origin]) for injection
... read more
BEDMINSTER, N.J., Dec. 21, 2012 /PRNewswire/ -- NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and Drug Administration (FDA) has approved Gattex(®) (Teduglutide [rDNA origin]) for Injection, for subcutaneous use ... read more